drug protocol number

BAY 80-6946 / 17322

drug sponsor

Bayer

drug study

BAY 80-6946/Copanlisib

drug trial site

King Abdulaziz University Hospital (Jeddah), King Abdullah Medical City (Makkah), King Fahad Specialist Hospital (Dammam)

drug status

Terminated

drug phase